Analyst Reco. BioSenic SA

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:29:34 2024-04-24 am EDT			5-day change	1st Jan Change
0.016 ^EUR	-18.37%		-20.79%	-73.86%

Apr. 11	Biosenic: launch of a debt restructuring plan	CF
Mar. 12	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	21-08-31
Bone Therapeutics Allogeneic Cell Therapy Product, ALLOB, Shows 90% Fusion Rate at 24 Months in Phase IIa Study in Lumbar Spinal Fusion	20-10-14	CI

No results for this search